Edesa Biotech Reports Dermatitis Study Enrolling Faster than Expected

Go back to Edesa Biotech Reports Dermatitis Study Enrolling Faster than Expected
(NASDAQ: EDSA) Delayed: 5.35 --0 (-0%)
Previous Close $5.35    52 Week High
Open $5.35    52 Week Low
Day High $5.35    P/E N/A 
Day Low $5.35    EPS
Volume 90